Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Neuropharmacology|August 10, 2014
Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: biochemical and electrophysiological characterizationPari Malherbe, Frédéric Knoflach, Anne Marcuz, et al.Journal of Medicinal Chemistry|November 21, 2007
From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profilingWolfgang Guba, Luke G Green, Rainer E Martin, et al.Journal of Medicinal Chemistry|February 6, 2015
Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approachHasane Ratni, Mark Rogers-Evans, Caterina Bissantz, et al.Drug Discovery Today|January 25, 2012
Can we discover pharmacological promiscuity early in the drug discovery process?Jens-Uwe Peters, Jérôme Hert, Caterina Bissantz, et al.ACS Medicinal Chemistry Letters|December 20, 2023
Novel Indane-Containing NBTIs with Potent Anti-Gram-Negative Activity and Minimal hERG InhibitionJohn G Cumming, Lukas Kreis, Holger Kühne, et al.Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonistsHassen Ratni, Theresa M Ballard, Caterina Bissantz, et al.Acta Crystallographica. Section D, Biological Crystallography|February 22, 2012
Catechol-O-methyltransferase in complex with substituted 3'-deoxyribose bisubstrate inhibitorsManuel Ellermann, Christian Lerner, Guillaume Burgy, et al.Journal of Medicinal Chemistry|December 3, 2002
Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compoundFelix Kratz, André Warnecke, Karin Scheuermann, et al.Chemmedchem|December 11, 2012
2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)Rainer E Martin, Caterina Bissantz, Olivier Gavelle, et al.Journal of Pharmacological and Toxicological Methods|July 9, 2019
Safety screening in early drug discovery: An optimized assay panelStefanie Bendels, Caterina Bissantz, Bernhard Fasching, et al.Pageof 4